Potential role of natural compounds as anti-angiogenic agents in cancer

MK Shanmugam, S Warrier, AP Kumar… - Current vascular …, 2017 - ingentaconnect.com
Background: Neovascularization, also known as angiogenesis, is the process of capillary
sprouting from pre-existing blood vessels. This physiological process is a hallmark event in …

VEGF receptor tyrosine kinases: key regulators of vascular function

A Álvarez-Aznar, L Muhl, K Gaengel - Current topics in developmental …, 2017 - Elsevier
Vascular endothelial growth factor receptor (VEGFR) tyrosine kinases are key regulators of
vascular development in vertebrates. Their activation is regulated through a family of …

CRH promotes human colon cancer cell proliferation via IL‐6/JAK2/STAT3 signaling pathway and VEGF‐induced tumor angiogenesis

X Fang, Y Hong, L Dai, Y Qian, C Zhu… - Molecular …, 2017 - Wiley Online Library
Corticotrophin‐releasing hormone (CRH) has been demonstrated to participate in various
diseases. Our previous study showed that its receptor CRHR1 mediated the development of …

Beyond organoids: in vitro vasculogenesis and angiogenesis using cells from mammals and zebrafish

M Ibrahim, MK Richardson - Reproductive Toxicology, 2017 - Elsevier
The ability to culture complex organs is currently an important goal in biomedical research. It
is possible to grow organoids (3D organ-like structures) in vitro; however, a major limitation …

Differential expression of VEGFA isoforms regulates metastasis and response to anti-VEGFA therapy in sarcoma

WR English, SJ Lunt, M Fisher, DV Lefley, M Dhingra… - Cancer research, 2017 - AACR
Elevated plasma concentrations of soluble VEGFA isoforms are associated with poor
prognosis in parallel with improved response to treatment with the anti-VEGFA antibody …

[HTML][HTML] A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands

LE Clegg, F Mac Gabhann - PLoS computational biology, 2017 - journals.plos.org
The splice isoforms of vascular endothelial growth A (VEGF) each have different affinities for
the extracellular matrix (ECM) and the coreceptor NRP1, which leads to distinct vascular …

Clinical pharmacology of anti-angiogenic drugs in oncology

P Gougis, J Wassermann, JP Spano, N Keynan… - Critical Reviews in …, 2017 - Elsevier
Abnormal vasculature proliferation is one of the so-called hallmarks of cancer. Angiogenesis
inhibitor therapies are one of the major breakthroughs in cancer treatment in the last two …

Systems pharmacology of VEGF165b in peripheral artery disease

LE Clegg, VC Ganta, BH Annex… - CPT: Pharmacometrics …, 2017 - Wiley Online Library
We built a whole‐body computational model to study the role of the poorly understood
vascular endothelial growth factor (VEGF) 165b splice isoform in peripheral artery disease …

[HTML][HTML] Peroxisome proliferator‑activated receptor γ mediates porcine placental angiogenesis through hypoxia inducible factor‑, vascular endothelial growth factor …

J Zhang, X Peng, A Yuan, Y Xie… - Molecular Medicine …, 2017 - spandidos-publications.com
Peroxisome proliferator-activated receptor (PPAR) γ has been reported to be implicated in
placentation in mice. Previous studies have demonstrated that PPARγ is also expressed in …

Expression of VEGF 111 and other VEGF-A variants in the rat uterus is correlated with stage of pregnancy

CM Whittington, K Danastas, GE Grau… - Journal of Comparative …, 2017 - Springer
Vascular endothelial growth factor A is a major mediator of angiogenesis, a critically
important process in vertebrate growth and development as well as pregnancy. Here we …